genesis research and development scitech presentation august 2006 biotechnology using biological systems living organisms or derivatives thereof to solve problems make useful products biotech segments red therapeutics diagnostics devices reagents consumables software green agbio white industrial materials industry 30 years old 5000 companies 700 public us market cap 500b 89b annual revenue 100 therapeutic marketed are grown on 200 million acres worldwide even the smallest is a global player international statistics usa europe asia pacific canada 72b 12b 3b 2b r&d 19b 5b 0 6b of 1 500 600 470 employees 146 68 000 12 7 440 363 120 140 81 491b 26b 15b 14b drug discovery stages pre clinical 5 10 phase i safety study 50 patients year ii efficacy 100s 1000s 2 more iii larger numbers success probabilities studies have shown trials commencing
